These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19563718)

  • 1. [The determination of medical reference values for tumor markers in cerebrospinal fluid].
    Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Cao XT
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):355-6. PubMed ID: 19563718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of tumor markers in the cerebrospinal fluid in the diagnosis of meningeal carcinomatosis].
    Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Huang DH; Zhang JT
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1192-4. PubMed ID: 20501426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS; Cheng BC; Ge W; Gao JF
    Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study.
    Bjerner J; Høgetveit A; Wold Akselberg K; Vangsnes K; Paus E; Bjøro T; Børmer OP; Nustad K
    Scand J Clin Lab Invest; 2008; 68(8):703-13. PubMed ID: 18609108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1.
    Yang J; Tang A; Ma J; Sun X; Ming L
    Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional Tumor Markers in Cerebralspinal Fluid in Patients with Elevated Serum Tumor Markers and without Central Nervous System Malignant Diseases.
    Liu ZJ; Shi Q; Lu B; Zhang Z; Tian CL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):539-542. PubMed ID: 27825410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum tumour markers in patients with chronic kidney disease.
    Xiaofang Y; Yue Z; Xialian X; Zhibin Y
    Scand J Clin Lab Invest; 2007; 67(6):661-7. PubMed ID: 17852811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary].
    Chen C; Li JD; Huang H; Feng YL; Wang LH; Chen L
    Ai Zheng; 2008 Jan; 27(1):92-5. PubMed ID: 18184473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of C12 multi-tumor marker protein chip in the diagnosis of gastrointestinal cancer: results of 329 surgical patients and suggestions for improvement.
    Yang XQ; Yan L; Chen C; Hou JX; Li Y
    Hepatogastroenterology; 2009; 56(94-95):1388-94. PubMed ID: 19950797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
    Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer.
    Chen ZQ; Huang LS; Zhu B
    Dis Markers; 2018; 2018():9845123. PubMed ID: 30647803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.
    Gebauer G; Müller-Ruchholtz W
    Anticancer Res; 1997; 17(4B):2939-42. PubMed ID: 9329569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imprecision of tumour biomarker measurements on Roche Modular E170 platform fulfills desirable goals derived from biological variation.
    Dolci A; Scapellato L; Mozzi R; Panteghini M
    Ann Clin Biochem; 2010 Mar; 47(Pt 2):171-3. PubMed ID: 20144978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of reference intervals of tumor markers in Korean adults].
    Woo HY; Kim YJ; Park H
    Korean J Lab Med; 2008 Jun; 28(3):179-84. PubMed ID: 18594168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Cerebrospinal Fluid Carbohydrate Antigen Series Biomarkers in Non-neoplastic Diseases.
    Shi Q; Tian C; Huang X; Pu C
    Ann Clin Lab Sci; 2015; 45(6):623-6. PubMed ID: 26663790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
    Ando S; Suzuki M; Yamamoto N; Iida T; Kimura H
    Anticancer Res; 2004; 24(3b):1941-6. PubMed ID: 15274381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid and serum carcinoembryonic antigen in brain tumors.
    Batabyal SK; Ghosh B; Sengupta S; Ghosh SN; Chatterjee R
    Neoplasma; 2003; 50(5):377-9. PubMed ID: 14628092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of freeze-thaw cycles on serum measurements of AFP, CEA, CA125 and CA19-9.
    Gao YC; Yuan ZB; Yang YD; Lu HK
    Scand J Clin Lab Invest; 2007; 67(7):741-7. PubMed ID: 17852813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A profile of tumor markers in the population of Kuwait.
    al-Sayer H; al-Bader A; Hussein T; Mathew A; Behbehani A; Dashti H; Farghaly M; Khorsheed M; Van Dalen A
    Anticancer Res; 1999; 19(3B):2369-72. PubMed ID: 10472358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.